Arcadia Biosciences (NASDAQ: RKDA) CEP Matt Plavan joined Proactive’s Steve Darling to discuss the company’s third-quarter results. Plavan also discussed some of the company highlights during that quarter including the latest on their research facilities.
Plavan also discussed their hemp operation and the expansion they had in three states.
Price: 2.75 USD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Director Interviews
Arcadia Biosciences Inc (NASDAQ:RKDA) posted fourth-quarter and full-year results after the bell Wednesday revealing plans for dramatic growth in 2020. Plavan says the company successfully laid the foundations for its research program in three geographic areas and established a vertically...
Prev article
